Episode Details

This episode is brought to you by Semafor Healthcare.

Delivered weekly from David Lim, Semafor Healthcare connects the dots between decisions in government, business, and technology to reveal how they impact the future of healthcare. Each edition will provide the analysis you need to understand and stay ahead of a rapidly changing landscape. Subscribe for free.

Last week, it was reported that President Joe Biden is considering Robert Califf to lead the Food and Drug Administration.

The appointment, which has yet to been made official, comes as a mid-November deadline to appoint an FDA Commissioner looms. Currently, the acting commissioner for the agency is Janet Woodcock.

On Health Affairs This Week, Senior Editors Jessica Bylander and Chris Fleming dive into Califf's consideration, why it's important the agency has a leader, and give an overview of the role FDA plays in regulation outside of drugs and medical devices.

Related Links:

• Biden Zeroes In On Califf To Head FDA As Deadline Nears (The Washington Post)
• The FDA Has Been Without A Permanent Leader For 8 Months As COVID Cases Climb (NPR)
• Seven Former FDA Commissioners: The FDA Should Be An Independent Federal Agency (Health Affairs)
• FDA Letter to President Biden, March 9, 2021 

Subscribe: RSS | Apple Podcasts | Spotify | Castro | Stitcher | Deezer | Overcast

Subscribe to Semafor Healthcare for free.